Cannabotech Ltd.
CNTC.TA
Tel Aviv Stock Exchange82.20
ILA
-4.00
- -
ISIN
IL0011769085
Return %
Stock
S&P500
1Y
-94.31
26.53
3Y
-99.46
76.60
5Y
-99.89
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Elchanan Shaked
- Full Time Employees
- 6
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- Rishon LeZion Israel
- IPO Date
- Jul 26, 2021
- Website
- cannabotech.com
- Similar Companies
- Business
- Cannabotech Ltd. is a biomedical enterprise focused on developing advanced botanical solutions that integrate cannabinoids and medicinal mushrooms. The company crafts specialized products for various health applications, including integrative oncology treatments for conditions like pancreatic and breast cancer, alongside a range of personalized preventive medicine offerings such as CBD-infused skincare, oils, and dietary supplements. Leveraging its unique M²CBD formula, Cannabotech aims to deliver enhanced well-being through synergistic effects. The firm, based in Rishon LeZion, Israel, is expanding its global footprint with market activities across the UK, the United States, and Asia.